Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Enhanced Survival With Lymphadenectomy In Early-stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis.
  1. Home
  3. Enhanced Survival With Lymphadenectomy In Early-stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis.

Related Experiment Video

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective

Jieshi Zhang1, Yuxiao Lin2, Jiong Zhou1

  • 1Department of Medical Affairs, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Oncology Research and Treatment
|March 17, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Lymphadenectomy improves survival for early-stage metachronous second primary lung cancer (MSPLC). This study found a significant survival benefit for MSPLC patients undergoing lymphadenectomy compared to those who did not.

Keywords:
Lymph node excisionMetachronous second primary neoplasmsNon-small cell lung cancerPrognosis

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

263
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.1K

Related Experiment Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

263
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.1K

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology
  • Pulmonary Medicine

Background:

  • Lymphadenectomy is crucial for resectable primary lung cancer.
  • Prognostic significance of lymphadenectomy in early-stage metachronous second primary lung cancer (MSPLC) is unclear.
  • This study evaluates lymphadenectomy's impact on MSPLC survival.

Purpose of the Study:

  • To assess the prognostic value of lymphadenectomy in early-stage MSPLC.
  • To compare overall survival rates between MSPLC patients with and without lymphadenectomy.
  • To provide evidence for surgical decision-making in MSPLC management.

Main Methods:

  • Retrospective cohort study using SEER Database (2004-2015).
  • Included patients surgically treated for stage I MSPLC.
  • Propensity score-matching and Cox proportional hazards model used for analysis.

    • Main Results:

    • 574 of 920 patients underwent lymphadenectomy.
    • Propensity score-matching created comparable groups of 255 patients each.
    • Lymphadenectomy group showed higher 5-year overall survival (58.7% vs. 43.9%, HR 0.76, p=0.002).

    Conclusions:

    • Lymphadenectomy is associated with improved overall survival in stage I MSPLC.
    • Findings support incorporating lymphadenectomy in MSPLC surgical management.
    • This provides guidance for thoracic surgeons treating MSPLC.